These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17169000)

  • 1. The Serratia-type hemolysin of Chromobacterium violaceum.
    Brumbach KC; Eason BD; Anderson LK
    FEMS Microbiol Lett; 2007 Feb; 267(2):243-50. PubMed ID: 17169000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of type-III secretion gene clusters in Chromobacterium violaceum.
    Betts HJ; Chaudhuri RR; Pallen MJ
    Trends Microbiol; 2004 Nov; 12(11):476-82. PubMed ID: 15488386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromobacterium haemolyticum sp. nov., a strongly haemolytic species.
    Han XY; Han FS; Segal J
    Int J Syst Evol Microbiol; 2008 Jun; 58(Pt 6):1398-403. PubMed ID: 18523185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression of the arsenic resistance operon in Chromobacterium violaceum ATCC 12472.
    Azevedo JS; Silva-Rocha R; Silva A; Peixe Carepo MS; Cruz Schneider MP
    Can J Microbiol; 2008 Feb; 54(2):137-42. PubMed ID: 18388983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA repair in Chromobacterium violaceum.
    Duarte FT; Carvalho FM; Bezerra e Silva U; Scortecci KC; Blaha CA; Agnez-Lima LF; Batistuzzo de Medeiros SR
    Genet Mol Res; 2004 Mar; 3(1):167-80. PubMed ID: 15100997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport genes of Chromobacterium violaceum: an overview.
    Grangeiro TB; Jorge DM; Bezerra WM; Vasconcelos AT; Simpson AJ
    Genet Mol Res; 2004 Mar; 3(1):117-33. PubMed ID: 15100993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Chromobacterium violaceum genes with potential biotechnological application in environmental detoxification.
    Carepo MS; Azevedo JS; Porto JI; Bentes-Sousa AR; Batista Jda S; Silva AL; Schneider MP
    Genet Mol Res; 2004 Mar; 3(1):181-94. PubMed ID: 15100998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of quorum sensing in multiple phenotypes of the bacterial pathogen Chromobacterium violaceum.
    de Oca-Mejía MM; Castillo-Juárez I; Martínez-Vázquez M; Soto-Hernandez M; García-Contreras R
    Pathog Dis; 2015 Mar; 73(2):1-4. PubMed ID: 25722489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the Major Hemolysin Gene Influences Expression of the Nonribosomal Peptide Synthetase Gene
    Petersen LM; LaCourse K; Schöner TA; Bode H; Tisa LS
    J Bacteriol; 2017 Nov; 199(21):. PubMed ID: 28784817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to stress and environmental adaptability of Chromobacterium violaceum.
    Hungria M; Nicolás MF; Guimarães CT; Jardim SN; Gomes EA; Vasconcelos AT
    Genet Mol Res; 2004 Mar; 3(1):102-16. PubMed ID: 15100992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromobacterium violaceum genome: molecular mechanisms associated with pathogenicity.
    Brito CF; Carvalho CB; Santos F; Gazzinelli RT; Oliveira SC; Azevedo V; Teixeira SM
    Genet Mol Res; 2004 Mar; 3(1):148-61. PubMed ID: 15100995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression in Chromobacterium violaceum.
    Silva R; Araripe JR; Rondinelli E; Urményi TP
    Genet Mol Res; 2004 Mar; 3(1):64-75. PubMed ID: 15100988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Chromobacterium violaceum by multiplex PCR targeting the prgI, spaO, invG, and sipB genes.
    Scholz HC; Witte A; Tomaso H; Al Dahouk S; Neubauer H
    Syst Appl Microbiol; 2006 Jan; 29(1):45-8. PubMed ID: 16423655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenyl caffeate, a major compound in manuka propolis, is a quorum-sensing inhibitor in Chromobacterium violaceum.
    Gemiarto AT; Ninyio NN; Lee SW; Logis J; Fatima A; Chan EW; Lim CS
    Antonie Van Leeuwenhoek; 2015 Aug; 108(2):491-504. PubMed ID: 26059863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of violacein biosynthesis by Chromobacterium violaceum.
    Antônio RV; Creczynski-Pasa TB
    Genet Mol Res; 2004 Mar; 3(1):85-91. PubMed ID: 15100990
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Batista JH; da Silva Neto JF
    Front Microbiol; 2017; 8():2213. PubMed ID: 29176969
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistance in Chromobacterium violaceum.
    Fantinatti-Garboggini F; Almeida Rd; Portillo Vdo A; Barbosa TA; Trevilato PB; Neto CE; Coêlho RD; Silva DW; Bartoleti LA; Hanna ES; Brocchi M; Manfio GP
    Genet Mol Res; 2004 Mar; 3(1):134-47. PubMed ID: 15100994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Zinc Transporter ZnuABC Is Critical for the Virulence of Chromobacterium violaceum and Contributes to Diverse Zinc-Dependent Physiological Processes.
    Santos RERS; da Silva Júnior WP; Harrison S; Skaar EP; Chazin WJ; da Silva Neto JF
    Infect Immun; 2021 Oct; 89(11):e0031121. PubMed ID: 34370507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis and functional characterization of the violacein biosynthetic pathway from Chromobacterium violaceum.
    August PR; Grossman TH; Minor C; Draper MP; MacNeil IA; Pemberton JM; Call KM; Holt D; Osburne MS
    J Mol Microbiol Biotechnol; 2000 Oct; 2(4):513-9. PubMed ID: 11075927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromobacterium violaceum, opportunist pathogenic bacteria in tropical and subtropical regions].
    Richard C
    Bull Soc Pathol Exot; 1993; 86(3):169-73. PubMed ID: 8219788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.